47 Followers on Owler
G1 is a North Carolina-based biopharmaceutical company that researches, develops, and commercializes gene therapies for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights
G1 is a North Carolina-based biopharmaceutical company that researches, develops, and commercializes gene therapies for the treatment of cancer... Read more
G1 Therapeutics CEO: Jack Bailey

CEO

Jack Bailey

CEO Approval Rating

84/100

2008

PublicAcquired by Pharmacosmos A/SNASDAQGTHX

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$58.2M
Employees
170
Funding
$349.4M

News

Acquisition
Aug 07, 2024
MarketScreener
G1 Therapeutics Was acquired by Pharmacosmos A/S for $405M

G1 Therapeutics Competitors

1Kite Pharma
2Perthera
3bluebird bio
4Parion Sciences
5Fate Therapeutics
6Zyngenia
7Tenax
8Universal Security Instruments
9Kadmon
10Eurasia Consulting
Unlock 10 + competitors

Trending Companies